Holen Sie sich die Stockscreener-App
1.1629
1.28%
-0.0121
Schlusskurs vom Vortag:
$1.175
Offen:
$1.21
24-Stunden-Volumen:
85,536
Relative Volume:
0.15
Marktkapitalisierung:
$10.47M
Einnahmen:
$895.50K
Nettoeinkommen (Verlust:
$-26.30M
KGV:
-0.0177
EPS:
-65.5728
Netto-Cashflow:
$-23.84M
1W Leistung:
+0.00%
1M Leistung:
+9.43%
6M Leistung:
-37.30%
1J Leistung:
-70.93%
1-Tages-Spanne:
$1.155
$1.22
1-Wochen-Bereich:
$1.12
$1.50
52-Wochen-Spanne:
$0.92
$8.20
Mainz Biomed N V Stock (MYNZ) Company Profile
Firmenname
Mainz Biomed N V
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie MYNZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MYNZ
Mainz Biomed N V
|
1.1551 | 10.65M | 895.50K | -26.30M | -23.84M | -65.57 |
|
TMO
Thermo Fisher Scientific Inc
|
612.51 | 227.87B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.66 | 165.99B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
710.57 | 56.89B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
147.68 | 41.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
245.55 | 41.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-14 | Eingeleitet | Maxim Group | Buy |
| 2024-11-25 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-11-21 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-21 | Eingeleitet | H.C. Wainwright | Buy |
Mainz Biomed N V Aktie (MYNZ) Neueste Nachrichten
Is Mainz Biomed N.V. (4TO) stock among top earnings playsWeekly Market Summary & AI Forecasted Stock Moves - ulpravda.ru
Is Mainz Biomed N.V. stock a safe buy before earningsMarket Weekly Review & Low Risk High Reward Ideas - ulpravda.ru
Earnings Report: Will Mainz Biomed N.V. stock see PE expansionJuly 2025 Big Picture & Entry Point Strategy Guides - ulpravda.ru
Entry Recap: How resilient is Mainz Biomed N.V. stock in market downturns2025 Growth vs Value & Low Drawdown Momentum Trade Ideas - ulpravda.ru
Is Mainz Biomed N.V. (4TO) stock undervalued after correction2025 Technical Patterns & Fast Exit and Entry Strategy Plans - ulpravda.ru
How strong is Mainz Biomed N.V. stock revenue growthMarket Sentiment Indicators & Big Gains Small Capital - ulpravda.ru
Is Mainz Biomed N.V. stock a buy for dividend growthStock Screening Results & Minimal Investment Portfolio - ulpravda.ru
Retail Trends: Will Mainz Biomed NV stock see PE expansionWeekly Profit Analysis & Safe Capital Growth Tips - moha.gov.vn
Mainz Biomed Provides Review of 2025 Highlights - Yahoo Finance
Earnings Risk: Why analysts upgrade Pony AI Inc Depositary Receipt stock2025 Short Interest & Weekly Consistent Profit Watchlists - moha.gov.vn
Is Mainz Biomed NV a good long term investmentBullish Engulfing Patterns & Insights From Wall Street Professionals - earlytimes.in
Form 424B5 MAINZ BIOMED N.V. - StreetInsider
Mainz Biomed (NASDAQ:MYNZ) Upgraded by Wall Street Zen to Hold Rating - Defense World
Mainz Biomed (NASDAQ:MYNZ) Stock Price Up 2.7% – Still a Buy? - Defense World
Why retail investors favor Mainz Biomed N.V. stockSwing Trade & Fast Gaining Stock Strategy Reports - Улправда
Why Mainz Biomed N.V. (4TO) stock is a strong buy callJuly 2025 Trade Ideas & AI Driven Price Predictions - Улправда
Why Mainz Biomed N.V. stock remains undervalued2025 EndofYear Setup & Risk Controlled Stock Pick Alerts - Улправда
Will Mainz Biomed N.V. stock reach all time highs in 20252025 Year in Review & Weekly Watchlist of Top Performers - Улправда
How Mainz Biomed N.V. stock reacts to inflationary pressuresJuly 2025 Sector Moves & Verified Momentum Watchlists - ulpravda.ru
2 Small-Cap Biotechs That Could Reward Patient Investors - Investing.com
2 Small-Cap Biotechs That Could Reward Patient Investors - sharewise.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Is Mainz Biomed N.V. stock positioned for long term growthJuly 2025 News Drivers & AI Forecast Swing Trade Picks - Newser
Mainz Biomed (Nasdaq: MYNZ) targets $150M shelf to advance cancer diagnostics - Stock Titan
Why Mainz Biomed N.V. (4TO) stock attracts wealthy investorsWeekly Market Outlook & Stock Portfolio Risk Control - Newser
Can Mainz Biomed N.V. (4TO) stock sustain free cash flow2025 Top Gainers & Fast Moving Stock Trade Plans - Newser
Is Mainz Biomed N.V. (4TO) stock expanding market penetrationJuly 2025 News Drivers & AI Forecast Swing Trade Picks - Newser
DoctorBox Adds Mainz Biomed's ColoAlert to Its Portfolio - marketscreener.com
Why Mainz Biomed N.V. (4TO) stock is favored by hedge fundsProduct Launch & Weekly High Conviction Ideas - Newser
Mainz Biomed (MYNZ) Stock Analysis Report | Financials & Insights - Benzinga
DoctorBox Adds Mainz Biomed’s ColoAlert(R) to Its Portfolio - GlobeNewswire
DoctorBox Adds Mainz Biomed’s ColoAlert® to Its Portfolio - TradingView — Track All Markets
Weekly Trades: Why hedge funds are buying Mainz Biomed N.V. stockJobs Report & Reliable Price Breakout Alerts - moha.gov.vn
Mainz Biomed N.V (MYNZ) looking to reclaim success with recent performance - Setenews
Mainz Biomed launches up to $2.6M at-the-market stock sale - Stock Titan
Mainz Biomed (NASDAQ:MYNZ) Shares Down 5.8% – What’s Next? - Defense World
Will Mainz Biomed N.V. stock see insider buyingJuly 2025 Closing Moves & Daily Profit Maximizing Trade Tips - newser.com
Is Mainz Biomed N.V. stock positioned well for digital economy2025 Bull vs Bear & Reliable Price Breakout Signals - newser.com
Is Mainz Biomed N.V. (4TO) stock attractive for dividend growth - newser.com
What’s the recovery path for long term holders of Mainz Biomed N.V.Earnings Growth Report & Stepwise Swing Trade Plans - newser.com
Can Mainz Biomed N.V. stock continue upward trend2025 Biggest Moves & Trade Opportunity Analysis Reports - newser.com
What margin trends mean for Mainz Biomed N.V. stockJuly 2025 Reactions & Breakout Confirmation Trade Signals - newser.com
Is a relief rally coming for Mainz Biomed N.V. holdersInflation Watch & Verified Technical Signals - newser.com
Finanzdaten der Mainz Biomed N V-Aktie (MYNZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.20%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):